Zurcher Kantonalbank (Zurich Cantonalbank) Pro Qr Therapeutics N.V. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 21, 2022	BUY	$0.9 - $8.39 $3,437 - $32,041	3,819 New	3,819 $3,000
Q4 2019 Jan 21, 2020	SELL	$5.84 - $10.51 $25,847 - $46,517	-4,426 Closed	0 $0
Q2 2019 Jul 30, 2019	BUY	$9.1 - $15.55 $9,755 - $16,669	1,072 Added 31.96%	4,426 $40,000
Q4 2018 Jan 25, 2019	BUY	$15.25 - $22.4 $51,148 - $75,129	3,354 New	3,354 $53,000

Others Institutions Holding PRQR

# of Institutions

Shares Held

17.4M

Call Options Held

37.7K

Put Options Held

21.3K

Privium Fund Management B.V.

5.63M
Shares

$12.2 Million
2.56% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

3.63M
Shares

$7.83 Million
0.01% of portfolio
Eco R1 Capital, LLC San Francisco, CA

1.84M
Shares

$3.97 Million
0.14% of portfolio
M28 Capital Management LP Stamford, CT

1.02M
Shares

$2.2 Million
1.76% of portfolio
Dafna Capital Management LLC Los Angeles, CA

906K
Shares

$1.96 Million
0.42% of portfolio

View Full List

About ProQR Therapeutics N.V.

Ticker PRQR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,362,096
Market Cap $154M
Description
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...

More about PRQR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account